CELIVIV Trademark

Trademark Overview

On Tuesday, August 11, 2009, a trademark application was filed for CELIVIV with the United States Patent and Trademark Office. The USPTO has given the CELIVIV trademark a serial number of 77801809. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2013. This trademark is owned by Glaxo Group Limited. The CELIVIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
celiviv

General Information

Serial Number77801809
Word MarkCELIVIV
Filing DateTuesday, August 11, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
Translation of Words in MarkThe wording "CELIVIV" has no meaning other than trademark significance.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, May 6, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 6, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 20, 2012EXTENSION 5 GRANTED
Wednesday, September 19, 2012EXTENSION 5 FILED
Wednesday, September 19, 2012TEAS EXTENSION RECEIVED
Friday, March 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 29, 2012EXTENSION 4 GRANTED
Monday, March 26, 2012EXTENSION 4 FILED
Monday, March 26, 2012TEAS EXTENSION RECEIVED
Wednesday, October 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2011EXTENSION 3 GRANTED
Monday, October 3, 2011EXTENSION 3 FILED
Monday, October 3, 2011TEAS EXTENSION RECEIVED
Tuesday, March 29, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2011EXTENSION 2 GRANTED
Monday, March 14, 2011EXTENSION 2 FILED
Monday, March 21, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2011TEAS EXTENSION RECEIVED
Saturday, September 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2010EXTENSION 1 GRANTED
Thursday, September 16, 2010EXTENSION 1 FILED
Thursday, September 16, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2010PUBLISHED FOR OPPOSITION
Monday, December 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 7, 2009ASSIGNED TO LIE
Wednesday, November 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, November 17, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, November 13, 2009ASSIGNED TO EXAMINER
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 14, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 14, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

celiviv pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic